Anticoagulation Both Over- and Under-Prescribed in A-Fib

Share this content:
Anticoagulation Both Over- and Under-Prescribed in A-Fib
Anticoagulation Both Over- and Under-Prescribed in A-Fib

WEDNESDAY, April 15, 2015 (HealthDay News) -- As many as one-quarter of people with atrial fibrillation who have a low risk of stroke are prescribed anticoagulation unnecessarily, a new study contends. The findings were published in a research letter online April 13 in JAMA Internal Medicine.

Gregory Marcus, M.D., of the University of California, San Francisco (UCSF), and colleagues collected information from 10,995 atrial fibrillation patients across the United States, all younger than 60. The patients were also all considered to have a low risk of stroke. Still, the researchers found that about 25 percent of them were prescribed oral anticoagulant therapy, contrary to current treatment guidelines.

Men were more likely to be prescribed anticoagulant therapy than women, as were older patients and overweight patients without stroke risk factors. The findings show that doctors may not be fully aware of the potential risks of these drugs, or the particularly low risk of stroke in certain atrial fibrillation patients, the researchers said.

"The irony is that there is a general push to get providers to prescribe these drugs, and they are also generally under-prescribed among many atrial fibrillation patients who actually need them," Marcus noted in a UCSF news release. "Our study suggests people are trying to do the right thing, but due to a lack of understanding of some of the critical nuances, go too far in that direction in low-risk patients."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »